Robert H. Lurie Comprehensive Cancer Center Northwestern University is a clinical research site located in Chicago, Illinois, United States 60611.
Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.
Robert H. Lurie Comprehensive Cancer Center Northwestern University has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: HER2-negative Breast Cancer Patients With Brain Metastases, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia.
Sponsors: Biostar Pharma, Inc., Millennium Pharmaceuticals, Inc..
Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Robert H. Lurie Comprehensive Cancer Center Northwestern University has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Robert H. Lurie Comprehensive Cancer Center Northwestern University has 2 clinical trials on record, with 1 currently active. Their work covers HER2-negative Breast Cancer Patients With Brain Metastases, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia.
Robert H. Lurie Comprehensive Cancer Center Northwestern University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.